Description
Patients with chronic lymphocytic leukemia have variable outcome. ZAP70 can predict patients who have aggressive disease and need aggressive therapy.
ZAP70
Patients with chronic lymphocytic leukemia have variable outcome. ZAP70 can predict patients who have aggressive disease and need aggressive therapy.
TAT:
Specimen Type:
Flowcytometry Single Test
Other Tests
-
98%
Adenosine Deaminase (ADA)
Evaluation of servere combined immunodeficiency syndrome and Hemolytic anemia of obscure cause
Adenosine Deaminase (ADA)
Evaluation of servere combined immunodeficiency syndrome and Hemolytic anemia of obscure cause
- 60%
-
60%
-
78%
Reviews
There are no reviews yet.